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ABSTRACT: Thermal ﬂuctuations cause proteins to adopt
an ensemble of conformations wherein the relative stability
of the diﬀerent ensemble members is determined by the
topography of the underlying energy landscape. “Folded”
proteins have relatively homogeneous ensembles, while
“unfolded” proteins have heterogeneous ensembles. Hence,
the labels “folded” and “unfolded” represent attempts to
provide a qualitative characterization of the extent of
structural heterogeneity within the underlying ensemble.
In this work, we introduce an information-theoretic order
parameter to quantify this conformational heterogeneity.
We demonstrate that this order parameter can be estimated
in a straightforward manner from an ensemble and is
applicabletobothunfoldedandfoldedproteins.Inaddition,
a simple formula for approximating the order parameter
directly from crystallographic B factors is presented. By
applyingthesemetricstoalargesampleofproteins,weshow
that proteins span the full range of the order disorder axis.
A
ll proteins undergo thermal ﬂuctuations that cause them to
sample a variety of diﬀerent conformations, where the
dominant conformations correspond to local minima on the
protein’s energy landscape. A conformational ensemble is a
description of the protein in terms of these low-energy con-
formationsandtheirrelativestabilities,orpopulationweights.An
ensemble of conformations may be homogeneous or hetero-
geneous, corresponding to folded and unfolded proteins,respec-
tively. The labels “folded” and “unfolded” qualitatively describe
theheterogeneityofanensemble,butthiscategoricaldescription
obscuresthefactthatproteindisorderisacontinuouspropertyof
an ensemble that can be quantiﬁed.
Many recent advances in structural biology have focused on
the development of methods for describing biomolecules using
ensembles ofstructures.
2 7For example,intrinsically disordered
proteins (IDPs), which possess very heterogeneous ensembles
consisting of a diverse set of highly populated conformations,
have been indentiﬁed.
2,3,8 10 In addition, it is now recognized
that deviations from the native state often play an important role
in protein function and disease, even for proteins that are
considered to be well-described by a single conformation under
physiological conditions.
4,11 14 For instance, non-native struc-
tures play a critical role in molecular recognition,
4 enzymatic
catalysis,
11,12,15 and prion diseases.
16,17 In order to understand the
role of structural disorder in protein function and disease, it is
necessary to be able to measure the disorder of a conformational
ensemble. To accomplish this, we deﬁne an order parameter
derived from information theory to quantify the degree of
disorder in an ensemble.
Weﬁrstunambiguouslydeﬁneouruseoftheterm“ensemble”.
An ensemble comprises a set of structures, S = {s1, s2, ..., sn}, and
thesetoftheircorrespondingweights,W={w1,w2,...,wn},where
wi represents the probability that the protein adopts structure si.
We propose that an order parameter O for protein ensembles
shouldhavethefollowingproperties:(1)0eOe1;(2)O=1if
and only if the protein adopts a single conformation (with no
conformational ﬂuctuations) throughout its biological lifetime;
(3) O = 0 if the protein equally populates an inﬁnite number of
structurally dissimilar conformations. Therefore, O should be
related to the entropy of the population weights and serve as a
measure of structural dissimilarity among the conformations in
the ensemble. An order parameter that satisﬁes these properties
is given by
O ¼ ∑
n
i¼1
wi log2 1 þ ∑
n
j¼1
wj exp  
D2ðsi,sjÞ
2ÆD2æ
 ! "#
ð1Þ
where D
2(si,sj) is the CR coordinate mean-square distance
(MSD) between structures si and sj and ÆD
2æ is the average
pairwise MSD due to the ﬂuctuations of a typical protein
structure at some prespeciﬁed temperature. In the Supporting
Information(SI),weprovideaderivationofeq1,discusssomeof
its properties, and describe how simulations were used to
estimate ÆD
2æ = 2.75 Å
2.
A physical interpretation for O emerges by considering the
relationship between the order parameter and the number of
conformations in the ensemble. As shown in the SI, O in eq 1 is
bounded as log2(1 þ 1/n) e O e 1. Since O g log2(1 þ 1/n),
the minimum number of conformations in the ensemble is n*=
(2
O   1)
 1. That is, n* is the smallest number of conformations
capable of producing the amount of disorder characterized by O.
By deﬁnition, an IDP is a protein with a high degree of
conformational heterogeneity.
9 Although these proteins are
natively unfolded, understanding just how disordered these
molecules are is an important question in and of itself. One way
to approach this is to compare the order parameter of an IDP
ensemble to that of a simple random coil ensemble of the same
size. We recently constructed a conformational ensemble for the
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K18 isoform of Tau, which is a 130-residue peptide that consists
ofthefourmicrotubulebindingrepeatregions.
3Tauproteinisan
IDP that has been extensively studied because of its proposed
roles in a number of human diseases, such as Alzheimer’s
dementia, a common neurodegenerative disorder that aﬀects
millions of individuals in the United States each year.
18,19
TheK18ensemblewasconstructedbyweightingastructurally
diverse set of 300 conformations in such a way that observables
calculated from the ensemble agreed with experimental data.
However, as we have previously shown, agreement with experi-
ment alone is insuﬃcient to ensure that any given ensemble is
correct.
3 Therefore, our Bayesian weighting (BW) algorithm,
which is based on techniques from Bayesian statistics, provides
an additional uncertainty metric called the posterior divergence
(or the uncertainty parameter), which quantiﬁes the uncertainty
in the resulting ensemble. Moreover, the BW algorithm can be
used to compute error bounds for calculated observables arising
from the model.
The 300 conformations that make up the K18 ensemble are
showninFigure1A.Asdiscussedinourpriorwork,theensemble
has calculated observables that agree with experiment (e.g.,
Figure 1B), and the calculated uncertainty parameter in the
underlying model is relatively low.
3 The order parameter and
minimal ensemble size of K18 computed from this ensemble are
O=0.045(0.005andn*=32(3,respectively,wheretheerrors
correspond to approximate 95% conﬁdence regions. For com-
parison, we calculated the order parameter for a random coil
model of K18 from an ensemble of 300 structures generated
using a previously described algorithm that employs sequence-
speciﬁc backbone dihedral angle statistics and excluded volume
interactions.
20,21 The order parameter calculated from this ran-
dom coil model was ORC ≈ 0.005. It is striking that the order
parametersfortheBWK18ensembleandtherandomcoilmodel
diﬀer by an order of magnitude, providing an intriguing bit of
evidence for residual structure in this IDP. Furthermore, this
conclusion can be drawn with a high degree of conﬁdence
because the order parameter calculated from the random coil
model falls well outside of the 95% Bayesian conﬁdence interval
for the order parameter of the BW K18 ensemble. As more
ensemblesaredeterminedforotherIDPs,itwillbeinterestingto
see whether there is a similar amount of residual structure for
other disordered proteins.
While the data on disordered proteins are sparse, there is a
wealth of information about the conformations of proteins that
have more homogeneous ensembles (i.e., folded proteins).
Because a signiﬁcant portion of these data were obtained from
crystallographic studies, it is useful to have a corresponding
formula for the order parameter in terms crystallographic data.
Informationaboutensembleheterogeneitycanbeobtainedfrom
B factors, assuming that the contributions to the B factors from
sources of noise (e.g., crystal disorder) are negligible. Kuzmanic
and Zagrovic recently derived a relationship between the B
factors and the ensemble-averaged mean-square deviation be-
tween structures.
22 As discussed in the SI, this relation can be
used to derive the following approximation for the order para-
meter:
O   log2 1 þ exp  
1
2ÆD2æ ∑
N
i¼1
3Bi
4π2N
 ! "#
ð2Þ
where N is the number of CR atoms with listed B factors. The
order parameter computed from a protein’s B factors describes
the ﬂexibility of the protein under the particular set of experi-
mental conditions. For example, if the structure was obtained in
the presence of a ligand, then the order parameter describes the
heterogeneity of the bound form and could potentially be
diﬀerent from what would have been obtained for the protein’s
unbound state.
To study the range of order parameters found in folded
proteins, we collected X-ray crystallographic structures having
a resolution of less than 2.0 Å and an Rfree value less than 0.2 and
containing only a single model from the Protein Data Bank
(PDB) as of November 22, 2010.
23 We computed the order
parameter for each of the resulting 5881 structures from the
corresponding B factors using the approximation given by eq 2.
As shown in Figure 2A, these values spanned the range from
∼0.5 to ∼1. An important observation is that this range includes
a number of proteins with minimum ensemble sizes of two or
Figure 1. BW ensemble forK18 Tau. (A)The 300 conformations used
to construct the ensemble, aligned via CR atoms. (B) Residual dipolar
couplings (RDCs) predicted from the ensemble using PALES
1 com-
pared to those measured experimentally.
Figure 2. Protein conformational heterogeneity as determined using
crystallographic B factors. (A) Plots of order parameters (blue) and
minimal ensemble sizes (red) for a large sample of proteins calculated
from crystallographic B factors. (B) Structure of human PIM-1 kinase
(PDB code 2BZH), which had the smallest order parameter.
(C) Structure of a peptide model of prion ﬁbrils (PDB code 3FVA),
which had the largest order parameter.10024 dx.doi.org/10.1021/ja203075p |J. Am. Chem. Soc. 2011, 133, 10022–10025
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more conformations. The smallest order parameter (O ≈ 0.5)
belongedtoPDBcode2BZH,astructureofhumanPim-1kinase
complexed with a ruthenium-containing ligand (Figure 2B).
24 It
is interesting to note that this corresponds to an eﬀective
ensemble size greater than 2 (i.e., the protein is not accurately
described by a single structure). Pim-1 is an important drug
target because of its role as an oncogenic protein that has been
implicated in a number of cancers.
25,26 Many candidate drugs
bind in the vicinity of a glycine rich P-loop that forms part of the
binding pocket for ATP (Pim-1’s natural ligand).
25 It has been
suggestedthat theﬂexibility oftheP-loop region inother kinases
is important for ligand binding via an induced-ﬁt mechanism.
25
At the other end of the spectrum, the largest order parameter
(O ≈ 1) was obtained for PDB code 3FVA, the NNQNTF
segment from elk prion protein, a model of prion ﬁbrils
(Figure 2C).
27 This peptide was found to pack into two “steric
zipper”polymorphsthatarebothhighlystableandseparatedbya
large energy barrier.
27 In addition, the high degree of order of
theseﬁbrilsmayplayan important role inprion-based pathogenesis
by sequestering regions of the peptide that would be vulnerable to
enzymatic cleavage and thus preventing proteolysis.
27,28
In addition, we computed values of the order parameter from
ensembles constructed using simulations obtained from the
Dynameomics Project.
29 33 The Dynameomics.org database
contains molecular dynamics (MD) simulations at 298 K that
are at least 31 ns in duration for a selection of proteins corres-
ponding to the 100 most common structural folds. The all-atom
simulations were conducted with the in lucem molecular me-
chanics (ilmm) program using the explicit solvent model
F3C.
34 36 Each ensemble consisted of 1000 structures taken in
evenly spaced 3 ps intervals from a 30 ns MD simulation. While
these ensembles were constructed from relatively short trajec-
tories(30ns),wenotethatapriorstudyexaminedasubsetofthe
trajectories that we used from the Dynameomics database and
found that these simulations yielded reasonable agreement with
experimentalNMRdata,includingNOEs,chemicalshifts,andS
2
order parameters.
33 This suggests that these data provide a
reasonable representation of each protein’s accessible states in
solution. Nevertheless, we recognize the likelihood that addi-
tional sampling would yield a more diverse assortment of
accessible conformations; therefore, the order parameters calcu-
lated from these trajectories likely represent an upper bound on
the true value of the order parameter that would be obtained
from a trajectory of inﬁnite length.
The order parameters were calculated using these structures
and eq1, where the weight ofeach structure wasset towi= 1/1000.
AsshowninFigure3A,theorderparametersspantherangefrom
∼0.3to∼0.9.ThefactthatthestructuresobtainedfromtheMD
simulations often yielded lower values for the order parameter
suggests that some proteins exhibit more structural heterogene-
ity in solution than in a crystal (an observation that is consistent
with previous studies
37 39) and/or that the use of B factors to
approximate the order parameter neglects regions with missing
electron density that may be highly ﬂexible. Despite the diﬀer-
ences between values calculated from the crystallographic
B factors and the MD trajectories, the two data sets demonstrate
that folded proteins cover a large portion of the order disorder
axis, including regions corresponding to proteins with multiple
conformational states.
The smallest order parameter (O ≈ 0.3) belonged to oryza-
cystatin-I, a cysteine proteinase inhibitor from a species of rice.
40
The structure of the 102 amino acid protein (PDB code 1EQK)
was determined by NMR analysis (Figure 3B). Both the N- and
C-terminal regions are relatively unstructured, a property that
is conserved in cysteine proteinase inhibitors from other
species.
40 42 Moreover, docking studies of a related protein
suggested that the ﬂexibility of the N-terminal region may be
important for recognition of the target enzyme.
41 The largest
order parameter from the simulation data set (O ≈ 0.9) was
obtained for a 41-residue antifungal peptide called EAFP2 that
contains 5-disulﬁde bonds.
43 45 The structure of EAFP2 was
determined by both NMR analysis
45 and X-ray crystallography
44
(Figure 3C). The highly ordered nature of this peptide is
consistent with the fact that it maintains its activity even at
100  C.
43 Furthermore, this rigidity may be an important
functional characteristic, given that similar disulﬁde bonding
patterns have been observed in other antifungal peptides.
43 45
The picture of the protein order disorder axis that we have
obtained from these studies is materially diﬀerent from the way
thatconformationalheterogeneityistypicallydiscussed.First,we
want to re-emphasize that proteins, both folded and unfolded,
span a large range of the order disorder axis and that the ability
to quantify the heterogeneitywithin agiven ensemblerepresents
a new way to view (and make quantitative statements about)
protein ensembles. Thus, instead of classifying proteins into
mutually exclusive “folded” or “unfolded” categories, it is im-
portant to quantify the actual extent of heterogeneity within the
ensemble. In this sense, our metrics provide a language for
describing protein ﬂexibility that will allow thorough studies of
protein order and disorder using a multitude of biophysical
techniques. From amyloid-like ﬁbrils on one end of the axis to
IDPs on the other, it is clear that conformational heterogeneity
Figure 3. Protein conformational heterogeneity as obtained from MD
simulations.(A)Plotsoforderparameters(blue)andminimalensemble
sizes (red) calculated for a sample of protein folds from simulations in
the Dynameomics database. The sample corresponded to 88 of the top
100 most common structural folds in the database, for which we were
able to obtain the data required to compute the order parameter.
(B) NMR structure of oryzacystatin-I (PDB code 1EQK), which had
the smallest order parameter. (C) Structure of the antifungal peptide
EAFP2 (PDB code 1P9G), which had the largest order parameter.10025 dx.doi.org/10.1021/ja203075p |J. Am. Chem. Soc. 2011, 133, 10022–10025
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has important implications for understanding disease states as
well as normal protein function.
’ASSOCIATED CONTENT
b S Supporting Information. Mathematical derivations and
discussion, details of simulation data, and a ﬁgure illustrating the
qualityoftheapproximationsusedtoderiveeq2.Thismaterialis
available free of charge via the Internet at http://pubs.acs.org.
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